383 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab http://www.zacks.com/stock/news/261265/amgen-amgn-submits-bla-to-fda-for-migraine-drug-erenumab?cid=CS-ZC-FT-261265 May 19, 2017 - Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.
Aerie's Ophthalmic Candidate Positive in Registration Trial http://www.zacks.com/stock/news/261948/aeries-ophthalmic-candidate-positive-in-registration-trial?cid=CS-ZC-FT-261948 May 25, 2017 - Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan.
Teva (TEVA) Launches Glumetza Generic, Inks Deal with Otsuka http://www.zacks.com/stock/news/260741/teva-teva-launches-glumetza-generic-inks-deal-with-otsuka?cid=CS-ZC-FT-260741 May 16, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) announced the launch of a generic version of Valeant Pharmaceuticals International, Inc.'s (VRX) diabetes drug, Glumetza, in the U.S.
Saint Agnes continues to scout for tenants at Gibbons Commons development http://feeds.bizjournals.com/~r/industry_20/~3/q2pAk5IHwhQ/saint-agnes-continues-to-scout-for-tenants-at.html Jun 21, 2017 - The project on 32 acres at the former Cardinal Gibbons High School site.
AGN: Mizuho reits Buy http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20170609055847 Jun 09, 2017 - Mizuho issues rating change for AGN
Sarepta Appoints Ex-Allergan Executive as CEO and President http://www.zacks.com/stock/news/266054/sarepta-appoints-ex-allergan-executive-as-ceo-and-president?cid=CS-ZC-FT-266054 Jun 29, 2017 - Sarepta Therapeutics, Inc. (SRPT) announced the appointment of Douglas S. Ingram as the new chief executive officer (CEO).
Podcast: Saint Agnes CEO on health care law, changing demands http://feeds.bizjournals.com/~r/industry_6/~3/CMubnTqJmS4/podcast-saint-agnes-ceo-on-health-care-law.html Jul 03, 2017 - Keith Vander Kolk believes health care has become to politicized. Vander Kolk, the CEO of Saint Agnes Healthcare, says both Republicans and Democrats care too much about who wins and who loses, and are overlooking conversations about the impact of health care legislation and bypassing discussions on actual policy. On this week's episode of the BaltBizCast, reporter Morgan Eichensher talks to Vander Kolk about the various health care bills floating around Congress, and what the uncertainty means…
Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone https://www.fool.com/investing/2017/08/03/heres-why-teva-pharmaceuticals-industries-ltd-adr.aspx?source=iedfolrf0000001 Aug 03, 2017 - Shares plunge after the company reports dreadful second-quarter results and slashes its dividend payment.
Allergan Plc (AGN) Q2 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4094472-allergan-plc-agn-q2-2017-results-earnings-call-transcript?source=feed_sector_healthcare Aug 03, 2017 - Allergan Plc (NYSE:AGN)Q2 2017 Earnings CallAugust 03, 2017 8:30 am ETExecutivesDaphne Karydas - Allergan PlcBrenton L. Saunders - Allergan PlcWilliam J. Meury - Allergan PlcC. David Nicholson, Ph.D.
Allergan's Patent Loophole Could Be a Huge Gift for Pfizer https://www.fool.com/investing/2017/09/11/allergans-patent-loophole-could-be-a-huge-gift-for.aspx?source=iedfolrf0000001 Sep 11, 2017 - An announcement from Allergan of a novel way to defend against patent challenges could be just what Pfizer needs.

Pages: 1234567891011...39

<<<Page 6>